Quarterly Technology review from Zeus Capital: January 2022

Zeus Capital provides its Technology Quarterly Review for Q1 2022. All subsectors de-rated in the quarter, largely driven by companies specific issues. Top share price performance was led by rebounds in oversold and undervalued companies, potentially indicating market rotation towards value stocks. Marketplaces and UK Software & Services are the most highly valued subsectors whilst Managed Services remains the lowest multiple subsector.

Our quarterly deep dive highlights the rapid progress of AI and Data Analytics technologies. The capabilities of AI has accelerated and is now advancing faster than even Moore’s Law, driven by exponential data proliferation and algorithmic and hardware innovations. Deep learning technologies are now surpassing human accuracy in computer vision, voice recognition, and speech synthesis and driving major advances in machine translation, game playing, drug discovery, credit assessment and robotics. The AI software market is valued at $35m in 2021E and forecast to grow 38% CAGR 2021-25. Investment in AI software is being enabled by the broad adoption of cloud data technology, which provides the foundation for higher levels of data processing and analysis. Financial services and intelligence agencies are leading adopters of AI and Data Analytica software, driven by high data intensity. We map key AI and Data Infrastructure subsectors in our report. UK AI and Data Analytics companies include Insig AI (INSG), Chorus Intelligence (private), D4t4 (D4T4), FD Technologies (FDP) and Darktrace (DARK).

To read the full review, click here

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    Zeus Capital

    More articles like this

    Guild Esports sign two-year gaming chair sponsorship with Razer

    Guild Esports plc (LON:GILD; OTCQB: GULDF), a global teams organisation and lifestyle brand, has welcome Razer as the Company’s Official Gaming Chair Partner with the signing of a two-year global sponsorship deal. The total contract value, which

    Redde Northgate trading ahead of expectations

    Redde Northgate plc (LON:REDD), the leading integrated mobility solutions platform providing services across the vehicle lifecycle, has announced a trading update for the year ended 30 April 2022, ahead of its results for the year scheduled

    Inchcape

    Inchcape update on Russian operations

    Inchcape plc (LON:INCH) is deeply saddened by the ongoing conflict in Ukraine and the enormous humanitarian impact on all those affected. We share the hopes of the world for a peaceful resolution. In light of the current

    STRIX GROUP PLC ORD 1P

    Strix Group to conduct investor presentation on 31st March 2022

    Strix Group plc (LON:KETL), the global leader in the design, manufacture and supply of kettle safety controls and other complementary water temperature management components will be conducting an investor presentation covering their Full Year results to the period

    City of London Investment Group plc

    City of London Investment Group Barry Olliff increases holding

    City of London Investment Group plc (LON:CLIG), a leading specialist asset management group offering a range of institutional and retail products investing primarily in closed-end funds, stated that it has been notified that Stable View III LP,

    CentralNic

    CentralNic Group continue to beat expectations (Analyst Interview)

    CentralNic Group Plc (LON:CNIC) is the topic of conversation when Bob Liao Director and Research Analyst at Zeus Capital joins DirectorsTalk Interviews. Bob provides us with an overview of VGL, explains how the acquisition fits in with CentalNic’s business,

    Guild Esports wins fifth major trophy

    Guild Esports plc (LON:GILD; OTCQB: GULDF), a global team organisation and lifestyle brand, has announced that it has won its fifth major trophy after its Fortnite pro-player, Henrik Mclean (‘Hen’), achieved first place in the prestigious Fortnite

    Oncimmune signs new commercial follow-on contract 

    Oncimmune Holdings plc (LON:ONC), the leading global immunodiagnostics group, has announced the signing of a new commercial follow-on contract with a world-leading medical research organisation based in the US, to validate the findings from a previous